Name: CNS Pharmaceuticals
Price range: $

The link you have selected will take you to a site outside CNSPharma.com

CNS Pharmaceuticals does not review or control the content of any non-CNS-Pharmaceuticals site. CNS Pharmaceuticals does not endorse and is not responsible for the accuracy, content, practices, or standards of any non-CNS-Pharmaceuticals sources.

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual Report to Security Holders

Other definitive proxy statements

Preliminary proxy statement providing notification matters to be brought to a vote

Prospectus [Rule 424(b)(5)]

General form for quarterly reports under Section 13 or 15(d)

Statement of acquisition of beneficial ownership by individuals

Current report pursuant to Section 13 or 15(d)

Current report pursuant to Section 13 or 15(d)

Notice